Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02187497Phase 2Completed
A Phase 2 trial of telmisartan in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Jun 1998; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02187497.